San Fernando Valley Business Journal

SFV HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

MannKind Gains $16.7 Million From Building Sale

MannKind Corp. on Tuesday announced it has received the remaining $16.7 million after closing the sale of some of its former real estate at 28901-28903 N. Avenue Pain in Valencia.

Preview: Hospitals Move to Main Street

Moving clinics off hospital campuses into non-medical locations that are also prominent and convenient is a new strategy for many major health systems.

Amgen Stock Rises on Drug Application

The stock of Amgen Inc. rose more than 2 percent Wednesday following an announcement that the Thousand Oaks biotechnology firm has applied for the Food and Drug Administration’s approval to broaden the range of disease conditions that can be treated with its leukemia drug Blincyto.

Cigna Sues Anthem for Nearly $15 Billion

Health insurer Cigna Corp. on Tuesday announced it had terminated its merger agreement with Anthem Inc. and had filed a lawsuit seeking more than $13 billion in damages from the company.

Court Rejects Anthem’s Takeover of Cigna

A federal judge ruled in favor of the Justice Department in a civil antitrust lawsuit to block health insurer Anthem, Inc.’s acquisition of Cigna Corp.

Competitor to Amgen's Repatha Gets Reprieve

Amgen Inc.’s cholesterol drug Repatha will continue to have competition for the time being.

ApolloMed Launches Patient Platform

Glendale health management company Apollo Medical Holdings Inc. on Thursday announced the launch of its interactive platform Apollo Care Connect 4.0.

Atara Biotherapeutics Coming to Thousand Oaks

Atara Biotherapeutics Inc., a clinical-stage biopharmaceutical company headquartered in South San Francisco, will move its research and development division to Thousand Oaks by the end of the year, according to the Conejo Valley city.

FDA Approves Amgen Parathyroid Drug

Amgen Inc. on Tuesday announced that the U.S. Food and Drug Administration has approved its drug Parsabiv for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis.

IPC Medical Billing Lawsuit Settled

Knoxville-based TeamHealth Holdings has agreed to pay $60 million plus interest to settle a case brought against its subsidiary IPC Healthcare Inc., according to the Department of Justice.

Former Wal-Mart Exec Joins Amgen Board

Amgen Inc. on Friday announced it has appointed Charles Holley, the former chief financial officer of Wal-Mart Stores Inc., to its board of directors.

Germany Approves Second Sight Device

Second Sight Medical Products Inc. announced that the German health care system has approved reimbursement coverage for the Argus II Retinal Prosthesis system in certain hospitals throughout the country.

Amgen Reports Strong Quarter

Amgen Inc. reported financial results that beat analyst expectations for the fourth quarter.

MannKind Proposes Reverse Stock Split

MannKind Corp. plans a reverse stock split to remain listed on the Nasdaq Stock Market, pending shareholder approval.

Amgen 2017 Tour Pedaling to Santa Clarita

Santa Clarita will witness professional cyclists dash across the finish line this May as the city will host the completion of the fourth stage in the men’s race of the 2017 Amgen Tour of California.